B cells and antibodies in multiple sclerosis pathogenesis and therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 8, Issue 11, Pages 613-623
Publisher
Springer Nature
Online
2012-10-09
DOI
10.1038/nrneurol.2012.203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B Cell Repopulation After Alemtuzumab Induction-Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B Cells
- (2012) S. Heidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
- (2012) Luisa M. Villar ARCHIVES OF NEUROLOGY
- Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
- (2012) P. P. Tak et al. ARTHRITIS AND RHEUMATISM
- Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
- (2012) Sara J. Ireland et al. AUTOIMMUNITY
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- Vitamin D and multiple sclerosis
- (2012) Kelly C. Simon et al. CURRENT OPINION IN NEUROLOGY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
- (2012) Markus C Kowarik et al. Journal of Neuroinflammation
- The discovery and development of belimumab: the anti-BLyS–lupus connection
- (2012) William Stohl et al. NATURE BIOTECHNOLOGY
- Alemtuzumab more effective than interferon -1a at 5-year follow-up of CAMMS223 Clinical Trial
- (2012) A. J. Coles et al. NEUROLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses
- (2012) A. E. Anderson et al. RHEUMATOLOGY
- Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
- (2012) P. P. Ho et al. Science Translational Medicine
- Alemtuzumab as compared to alternative contemporary induction regimens
- (2012) John C. LaMattina et al. TRANSPLANT INTERNATIONAL
- Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
- (2012) Marie Cathrin Mayer et al. Therapeutic Advances in Neurological Disorders
- Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
- (2011) Ajit Singh Dhaunchak et al. ANNALS OF NEUROLOGY
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival
- (2011) R. M. Reijmers et al. BLOOD
- CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes
- (2011) J-F Lesesve et al. BONE MARROW TRANSPLANTATION
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Vitamin D and autoimmune thyroid diseases
- (2011) Shaye Kivity et al. Cellular & Molecular Immunology
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
- (2011) M. Kreuzaler et al. JOURNAL OF IMMUNOLOGY
- Opposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients
- (2011) Cinzia Zanotti et al. JOURNAL OF NEUROIMMUNOLOGY
- Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis
- (2011) Kathryn M. Brennan et al. JOURNAL OF NEUROIMMUNOLOGY
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
- (2011) Birgit Obermeier et al. JOURNAL OF NEUROIMMUNOLOGY
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
- (2011) Klaus Lehmann-Horn et al. Journal of Neuroinflammation
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
- (2011) Simone Mader et al. Journal of Neuroinflammation
- Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
- (2011) Susan S. Kim et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis
- (2011) Stephanie Knippenberg et al. Multiple Sclerosis Journal
- Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis
- (2011) F Sellebjerg et al. Multiple Sclerosis Journal
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy
- (2011) R. Hohlfeld et al. NEUROLOGY
- Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
- (2011) A. K. Probstel et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking and Multiple Sclerosis: An Updated Meta-Analysis
- (2011) Adam E. Handel et al. PLoS One
- N-Acetylcysteine Increases the Frequency of Bone Marrow Pro-B/Pre-B Cells, but Does Not Reverse Cigarette Smoking-Induced Loss of This Subset
- (2011) Victoria L. Palmer et al. PLoS One
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients
- (2010) Matthias Mehling et al. ANNALS OF NEUROLOGY
- Interferon Beta Treatment in Neuromyelitis Optica
- (2010) Jacqueline Palace et al. ARCHIVES OF NEUROLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice
- (2010) Seiichiro Ando et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- Impact of female cigarette smoking on circulating B cells in vivo: the suppressed ICOSLG, TCF3, and VCAM1 gene functional network may inhibit normal cell function
- (2010) Feng Pan et al. IMMUNOGENETICS
- Cigarette smoke-induced effects on bone marrow B-cell subsets and CD4+:CD8+T-cell ratios are reversed by smoking cessation: Influence of bone mass on immune cell response to and recovery from smoke exposure
- (2010) Jenny S. Fusby et al. INHALATION TOXICOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis
- (2010) A.J. Ligocki et al. JOURNAL OF NEUROIMMUNOLOGY
- Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis
- (2010) C Stauch et al. Multiple Sclerosis Journal
- Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
- (2010) Adi Vaknin-Dembinsky et al. Multiple Sclerosis Journal
- Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
- (2010) Chris J Hedegaard et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
- (2010) Sven Jarius et al. Nature Reviews Neurology
- Environmental factors and their timing in adult-onset multiple sclerosis
- (2010) Adam E. Handel et al. Nature Reviews Neurology
- Fingolimod is a potential novel therapy for multiple sclerosis
- (2010) Orhan Aktas et al. Nature Reviews Neurology
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis
- (2010) H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
- (2009) D. Bloom et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunoglobulins and complement in postmortem multiple sclerosis tissue
- (2009) Michael H. Barnett et al. ANNALS OF NEUROLOGY
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
- (2009) Gregory P. Owens et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab
- (2009) Maria del Pilar Martin et al. ARCHIVES OF NEUROLOGY
- Smoking and Disease Progression in Multiple Sclerosis
- (2009) Brian C. Healy et al. ARCHIVES OF NEUROLOGY
- Critical analysis of rituximab-induced serological changes in connective tissue diseases
- (2009) D. Cornec et al. AUTOIMMUNITY REVIEWS
- B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
- (2009) Mrinalini Kala et al. EXPERIMENTAL NEUROLOGY
- B Lymphocytes Exit Lymph Nodes through Cortical Lymphatic Sinusoids by a Mechanism Independent of Sphingosine-1-Phosphate-Mediated Chemotaxis
- (2009) Rajesh K. Sinha et al. IMMUNITY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
- (2009) Bernadette Pöllinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
- (2009) K. A. McLaughlin et al. JOURNAL OF IMMUNOLOGY
- Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis☆
- (2009) Elizabeth M. Cameron et al. JOURNAL OF NEUROIMMUNOLOGY
- Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis
- (2009) Evert-Jan Kooi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
- (2009) L. Zhang et al. JOURNAL OF NEUROSCIENCE
- Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
- (2009) A. K. Hedstrom et al. NEUROLOGY
- Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
- (2009) R. Zivadinov et al. NEUROLOGY
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
- (2009) T. Derfuss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Homogeneity of active demyelinating lesions in established multiple sclerosis
- (2008) Esther C. W. Breij et al. ANNALS OF NEUROLOGY
- Anti-Inflammatory Actions of Intravenous Immunoglobulin
- (2008) Falk Nimmerjahn et al. Annual Review of Immunology
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies
- (2008) Hans‐Christian von Büdingen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis
- (2008) Kaushal S. Gandhi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity?
- (2008) Sven Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
- (2008) Birgit Obermeier et al. NATURE MEDICINE
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
- (2008) Bettina Kuenz et al. PLoS One
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
- (2008) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started